Few drug labeling changes result from neonate studies

12/10/2013 | Family Practice News

Despite federal legislation that encourages pediatric drug research in the U.S., researchers found that only 11 of 24 neonatal drug labeling changes between 1997 and 2010 confirmed the drug's safety and effectiveness for newborns. Of the 28 drugs included in neonatal studies, almost half were not not used in neonatal intensive care units and almost a third of them were used in less than 60 babies. The findings were published in the journal JAMA Pediatrics.

View Full Article in:

Family Practice News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC